Global Retinal Biosimilars Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: GF73EDF2E5DEEN
QYResearch

Abstracts

This report focuses on the global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Biosimilars development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Novartis (Sandoz)
• Takeda
• Bayer
• Genentech
• Pfenex
• Reliance Life Sciences
• Hetero Drugs
• Intas Pharmaceuticals
• Santo Holding
• Regeneron Pharmaceuticals

Market segment by Type, the product can be split into

• Macular Degeneration Drugs
• Diabetic Eye Disease Drugs
• Macular Pucker Drugs
• Others

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Retinal Biosimilars status, future forecast, growth opportunity, key market and key players.
• To present the Retinal Biosimilars development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Biosimilars are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retinal Biosimilars Revenue
1.4 Market Analysis by Type
  1.4.1 Global Retinal Biosimilars Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Macular Degeneration Drugs
  1.4.3 Diabetic Eye Disease Drugs
  1.4.4 Macular Pucker Drugs
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Retinal Biosimilars Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Retinal Biosimilars Market Perspective (2015-2026)
2.2 Retinal Biosimilars Growth Trends by Regions
  2.2.1 Retinal Biosimilars Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Retinal Biosimilars Historic Market Share by Regions (2015-2020)
  2.2.3 Retinal Biosimilars Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Retinal Biosimilars Market Growth Strategy
  2.3.6 Primary Interviews with Key Retinal Biosimilars Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Retinal Biosimilars Players by Market Size
  3.1.1 Global Top Retinal Biosimilars Players by Revenue (2015-2020)
  3.1.2 Global Retinal Biosimilars Revenue Market Share by Players (2015-2020)
  3.1.3 Global Retinal Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retinal Biosimilars Market Concentration Ratio
  3.2.1 Global Retinal Biosimilars Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Retinal Biosimilars Revenue in 2019
3.3 Retinal Biosimilars Key Players Head office and Area Served
3.4 Key Players Retinal Biosimilars Product Solution and Service
3.5 Date of Enter into Retinal Biosimilars Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Retinal Biosimilars Historic Market Size by Type (2015-2020)
4.2 Global Retinal Biosimilars Forecasted Market Size by Type (2021-2026)

5 RETINAL BIOSIMILARS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Retinal Biosimilars Market Size by Application (2015-2020)
5.2 Global Retinal Biosimilars Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Retinal Biosimilars Market Size (2015-2020)
6.2 Retinal Biosimilars Key Players in North America (2019-2020)
6.3 North America Retinal Biosimilars Market Size by Type (2015-2020)
6.4 North America Retinal Biosimilars Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Retinal Biosimilars Market Size (2015-2020)
7.2 Retinal Biosimilars Key Players in Europe (2019-2020)
7.3 Europe Retinal Biosimilars Market Size by Type (2015-2020)
7.4 Europe Retinal Biosimilars Market Size by Application (2015-2020)

8 CHINA

8.1 China Retinal Biosimilars Market Size (2015-2020)
8.2 Retinal Biosimilars Key Players in China (2019-2020)
8.3 China Retinal Biosimilars Market Size by Type (2015-2020)
8.4 China Retinal Biosimilars Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Retinal Biosimilars Market Size (2015-2020)
9.2 Retinal Biosimilars Key Players in Japan (2019-2020)
9.3 Japan Retinal Biosimilars Market Size by Type (2015-2020)
9.4 Japan Retinal Biosimilars Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Retinal Biosimilars Market Size (2015-2020)
10.2 Retinal Biosimilars Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retinal Biosimilars Market Size by Type (2015-2020)
10.4 Southeast Asia Retinal Biosimilars Market Size by Application (2015-2020)

11 INDIA

11.1 India Retinal Biosimilars Market Size (2015-2020)
11.2 Retinal Biosimilars Key Players in India (2019-2020)
11.3 India Retinal Biosimilars Market Size by Type (2015-2020)
11.4 India Retinal Biosimilars Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Retinal Biosimilars Market Size (2015-2020)
12.2 Retinal Biosimilars Key Players in Central & South America (2019-2020)
12.3 Central & South America Retinal Biosimilars Market Size by Type (2015-2020)
12.4 Central & South America Retinal Biosimilars Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novartis (Sandoz)
  13.1.1 Novartis (Sandoz) Company Details
  13.1.2 Novartis (Sandoz) Business Overview and Its Total Revenue
  13.1.3 Novartis (Sandoz) Retinal Biosimilars Introduction
  13.1.4 Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2015-2020))
  13.1.5 Novartis (Sandoz) Recent Development
13.2 Takeda
  13.2.1 Takeda Company Details
  13.2.2 Takeda Business Overview and Its Total Revenue
  13.2.3 Takeda Retinal Biosimilars Introduction
  13.2.4 Takeda Revenue in Retinal Biosimilars Business (2015-2020)
  13.2.5 Takeda Recent Development
13.3 Bayer
  13.3.1 Bayer Company Details
  13.3.2 Bayer Business Overview and Its Total Revenue
  13.3.3 Bayer Retinal Biosimilars Introduction
  13.3.4 Bayer Revenue in Retinal Biosimilars Business (2015-2020)
  13.3.5 Bayer Recent Development
13.4 Genentech
  13.4.1 Genentech Company Details
  13.4.2 Genentech Business Overview and Its Total Revenue
  13.4.3 Genentech Retinal Biosimilars Introduction
  13.4.4 Genentech Revenue in Retinal Biosimilars Business (2015-2020)
  13.4.5 Genentech Recent Development
13.5 Pfenex
  13.5.1 Pfenex Company Details
  13.5.2 Pfenex Business Overview and Its Total Revenue
  13.5.3 Pfenex Retinal Biosimilars Introduction
  13.5.4 Pfenex Revenue in Retinal Biosimilars Business (2015-2020)
  13.5.5 Pfenex Recent Development
13.6 Reliance Life Sciences
  13.6.1 Reliance Life Sciences Company Details
  13.6.2 Reliance Life Sciences Business Overview and Its Total Revenue
  13.6.3 Reliance Life Sciences Retinal Biosimilars Introduction
  13.6.4 Reliance Life Sciences Revenue in Retinal Biosimilars Business (2015-2020)
  13.6.5 Reliance Life Sciences Recent Development
13.7 Hetero Drugs
  13.7.1 Hetero Drugs Company Details
  13.7.2 Hetero Drugs Business Overview and Its Total Revenue
  13.7.3 Hetero Drugs Retinal Biosimilars Introduction
  13.7.4 Hetero Drugs Revenue in Retinal Biosimilars Business (2015-2020)
  13.7.5 Hetero Drugs Recent Development
13.8 Intas Pharmaceuticals
  13.8.1 Intas Pharmaceuticals Company Details
  13.8.2 Intas Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Intas Pharmaceuticals Retinal Biosimilars Introduction
  13.8.4 Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2015-2020)
  13.8.5 Intas Pharmaceuticals Recent Development
13.9 Santo Holding
  13.9.1 Santo Holding Company Details
  13.9.2 Santo Holding Business Overview and Its Total Revenue
  13.9.3 Santo Holding Retinal Biosimilars Introduction
  13.9.4 Santo Holding Revenue in Retinal Biosimilars Business (2015-2020)
  13.9.5 Santo Holding Recent Development
13.10 Regeneron Pharmaceuticals
  13.10.1 Regeneron Pharmaceuticals Company Details
  13.10.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Regeneron Pharmaceuticals Retinal Biosimilars Introduction
  13.10.4 Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2015-2020)
  13.10.5 Regeneron Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Retinal Biosimilars Key Market Segments
Table 2. Key Players Covered: Ranking by Retinal Biosimilars Revenue
Table 3. Ranking of Global Top Retinal Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Retinal Biosimilars Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Macular Degeneration Drugs
Table 6. Key Players of Diabetic Eye Disease Drugs
Table 7. Key Players of Macular Pucker Drugs
Table 8. Key Players of Others
Table 9. Global Retinal Biosimilars Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Retinal Biosimilars Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Retinal Biosimilars Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Retinal Biosimilars Market Share by Regions (2015-2020)
Table 13. Global Retinal Biosimilars Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Retinal Biosimilars Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Retinal Biosimilars Market Growth Strategy
Table 19. Main Points Interviewed from Key Retinal Biosimilars Players
Table 20. Global Retinal Biosimilars Revenue by Players (2015-2020) (Million US$)
Table 21. Global Retinal Biosimilars Market Share by Players (2015-2020)
Table 22. Global Top Retinal Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biosimilars as of 2019)
Table 23. Global Retinal Biosimilars by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Retinal Biosimilars Product Solution and Service
Table 26. Date of Enter into Retinal Biosimilars Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 29. Global Retinal Biosimilars Market Size Share by Type (2015-2020)
Table 30. Global Retinal Biosimilars Revenue Market Share by Type (2021-2026)
Table 31. Global Retinal Biosimilars Market Size Share by Application (2015-2020)
Table 32. Global Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 33. Global Retinal Biosimilars Market Size Share by Application (2021-2026)
Table 34. North America Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Retinal Biosimilars Market Share (2019-2020)
Table 36. North America Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 37. North America Retinal Biosimilars Market Share by Type (2015-2020)
Table 38. North America Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 39. North America Retinal Biosimilars Market Share by Application (2015-2020)
Table 40. Europe Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Retinal Biosimilars Market Share (2019-2020)
Table 42. Europe Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Retinal Biosimilars Market Share by Type (2015-2020)
Table 44. Europe Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Retinal Biosimilars Market Share by Application (2015-2020)
Table 46. China Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 47. China Key Players Retinal Biosimilars Market Share (2019-2020)
Table 48. China Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 49. China Retinal Biosimilars Market Share by Type (2015-2020)
Table 50. China Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 51. China Retinal Biosimilars Market Share by Application (2015-2020)
Table 52. Japan Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Retinal Biosimilars Market Share (2019-2020)
Table 54. Japan Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Retinal Biosimilars Market Share by Type (2015-2020)
Table 56. Japan Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Retinal Biosimilars Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Retinal Biosimilars Market Share (2019-2020)
Table 60. Southeast Asia Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Retinal Biosimilars Market Share by Type (2015-2020)
Table 62. Southeast Asia Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Retinal Biosimilars Market Share by Application (2015-2020)
Table 64. India Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 65. India Key Players Retinal Biosimilars Market Share (2019-2020)
Table 66. India Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 67. India Retinal Biosimilars Market Share by Type (2015-2020)
Table 68. India Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 69. India Retinal Biosimilars Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Retinal Biosimilars Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Retinal Biosimilars Market Share (2019-2020)
Table 72. Central & South America Retinal Biosimilars Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Retinal Biosimilars Market Share by Type (2015-2020)
Table 74. Central & South America Retinal Biosimilars Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Retinal Biosimilars Market Share by Application (2015-2020)
Table 76. Novartis (Sandoz) Company Details
Table 77. Novartis (Sandoz) Business Overview
Table 78. Novartis (Sandoz) Product
Table 79. Novartis (Sandoz) Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 80. Novartis (Sandoz) Recent Development
Table 81. Takeda Company Details
Table 82. Takeda Business Overview
Table 83. Takeda Product
Table 84. Takeda Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 85. Takeda Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 90. Bayer Recent Development
Table 91. Genentech Company Details
Table 92. Genentech Business Overview
Table 93. Genentech Product
Table 94. Genentech Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 95. Genentech Recent Development
Table 96. Pfenex Company Details
Table 97. Pfenex Business Overview
Table 98. Pfenex Product
Table 99. Pfenex Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 100. Pfenex Recent Development
Table 101. Reliance Life Sciences Company Details
Table 102. Reliance Life Sciences Business Overview
Table 103. Reliance Life Sciences Product
Table 104. Reliance Life Sciences Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 105. Reliance Life Sciences Recent Development
Table 106. Hetero Drugs Company Details
Table 107. Hetero Drugs Business Overview
Table 108. Hetero Drugs Product
Table 109. Hetero Drugs Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 110. Hetero Drugs Recent Development
Table 111. Intas Pharmaceuticals Business Overview
Table 112. Intas Pharmaceuticals Product
Table 113. Intas Pharmaceuticals Company Details
Table 114. Intas Pharmaceuticals Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 115. Intas Pharmaceuticals Recent Development
Table 116. Santo Holding Company Details
Table 117. Santo Holding Business Overview
Table 118. Santo Holding Product
Table 119. Santo Holding Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 120. Santo Holding Recent Development
Table 121. Regeneron Pharmaceuticals Company Details
Table 122. Regeneron Pharmaceuticals Business Overview
Table 123. Regeneron Pharmaceuticals Product
Table 124. Regeneron Pharmaceuticals Revenue in Retinal Biosimilars Business (2015-2020) (Million US$)
Table 125. Regeneron Pharmaceuticals Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Retinal Biosimilars Market Share by Type: 2020 VS 2026
Figure 2. Macular Degeneration Drugs Features
Figure 3. Diabetic Eye Disease Drugs Features
Figure 4. Macular Pucker Drugs Features
Figure 5. Others Features
Figure 6. Global Retinal Biosimilars Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retinal Biosimilars Report Years Considered
Figure 11. Global Retinal Biosimilars Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Retinal Biosimilars Market Share by Regions: 2020 VS 2026
Figure 13. Global Retinal Biosimilars Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Retinal Biosimilars Market Share by Players in 2019
Figure 16. Global Top Retinal Biosimilars Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Biosimilars as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Retinal Biosimilars Revenue in 2019
Figure 18. North America Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Retinal Biosimilars Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Novartis (Sandoz) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novartis (Sandoz) Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bayer Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 31. Genentech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Genentech Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 33. Pfenex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfenex Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 35. Reliance Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Reliance Life Sciences Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 37. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Hetero Drugs Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 39. Intas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Intas Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 41. Santo Holding Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Santo Holding Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 43. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Regeneron Pharmaceuticals Revenue Growth Rate in Retinal Biosimilars Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed